ATE228836T1 - Verwendung von chromane und/oder chromene derivaten zur vermeidung von freien radikalen induzierten oxidativen reaktionen - Google Patents

Verwendung von chromane und/oder chromene derivaten zur vermeidung von freien radikalen induzierten oxidativen reaktionen

Info

Publication number
ATE228836T1
ATE228836T1 AT99500138T AT99500138T ATE228836T1 AT E228836 T1 ATE228836 T1 AT E228836T1 AT 99500138 T AT99500138 T AT 99500138T AT 99500138 T AT99500138 T AT 99500138T AT E228836 T1 ATE228836 T1 AT E228836T1
Authority
AT
Austria
Prior art keywords
chromanes
free radical
oxidative reactions
induced oxidative
radical induced
Prior art date
Application number
AT99500138T
Other languages
English (en)
Inventor
Lambiez Fernando Pons
Gonzalez Raquel Delgado
Duena Antonio Parente
Original Assignee
Lipotec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lipotec Sa filed Critical Lipotec Sa
Application granted granted Critical
Publication of ATE228836T1 publication Critical patent/ATE228836T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/18—Antioxidants, e.g. antiradicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/92—Oral administration

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Food Science & Technology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Pain & Pain Management (AREA)
  • Polymers & Plastics (AREA)
  • Birds (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Fats And Perfumes (AREA)
  • Cosmetics (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
AT99500138T 1998-09-16 1999-09-10 Verwendung von chromane und/oder chromene derivaten zur vermeidung von freien radikalen induzierten oxidativen reaktionen ATE228836T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES009801947A ES2154560B1 (es) 1998-09-16 1998-09-16 Composicion a base de derivados de cromanos y su uso para reducir quimicamente las reacciones oxidativas o inducidas por radicales libres.

Publications (1)

Publication Number Publication Date
ATE228836T1 true ATE228836T1 (de) 2002-12-15

Family

ID=8305178

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99500138T ATE228836T1 (de) 1998-09-16 1999-09-10 Verwendung von chromane und/oder chromene derivaten zur vermeidung von freien radikalen induzierten oxidativen reaktionen

Country Status (7)

Country Link
EP (1) EP1002533B1 (de)
JP (1) JP4723705B2 (de)
AT (1) ATE228836T1 (de)
DE (1) DE69904282T2 (de)
DK (1) DK1002533T3 (de)
ES (2) ES2154560B1 (de)
PT (1) PT1002533E (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19941595A1 (de) * 1999-09-01 2001-03-08 Basf Ag Verwendung von anellierten Benzolderivaten als Antioxidans oder Radikalfänger in kosmetischen Zubereitungen
AU2001242502A1 (en) * 2000-03-31 2001-10-15 Henkel Kommanditgesellschaft Auf Aktien Use of protease inhibitors in cosmetics and pharmacy
FR2808189B1 (fr) 2000-04-28 2004-03-05 Oreal Lipochroman-6 comme inhibiteur de no-synthase et utilisations
DE10259014A1 (de) 2002-12-16 2004-06-24 Henkel Kgaa Antioxidans-Kombinationen mit6,7-disubstituierten 2,2-Dialkylchromanen oder-chromenen
DE102004039729A1 (de) * 2004-08-16 2006-03-09 Beiersdorf Ag Kosmetische oder dermatologische Zubereitungen mit einem Gehalt an (-)2-Hydroxymethyl-2-Methyl-6-hydroxychromen bzw. einen Extrakt aus Pilzen der Art Daedalea quercina, (-)2-Hydroxymethyl-2-Methyl-6-hydrocychromen enthaltend
DE102006062501A1 (de) 2006-12-28 2008-07-03 Henkel Kgaa Kosmetische und dermatologische Öl-in-Wasser-Emulsionen mit selbstkonservierenden Eigenschaften
ES2310142B1 (es) 2007-06-15 2009-12-04 Lipotec S.A Compuestos reguladores de la pigmentacion.
EP2113242A1 (de) * 2008-05-02 2009-11-04 Pangaea Laboratories Limited Antioxidationsmittel für kosmetische, medizinische und pharmazeutische Zubereitungen
FR2934490B1 (fr) * 2008-08-01 2010-09-17 Lvmh Rech Utilisation dans une composition cosmetique du lipochroman-6 pour ameliorer l'eclat du teint de la peau, notamment du visage
DE102009017612A1 (de) * 2009-04-20 2010-10-21 Henkel Ag & Co. Kgaa Hautbehandlungsmittel gegen Hautalterung I
DE102009026414A1 (de) 2009-05-22 2010-11-25 Henkel Ag & Co. Kgaa Hautbehandlung zur Porenverfeinerung
DE102009027024A1 (de) 2009-06-18 2010-12-23 Henkel Ag & Co. Kgaa Antifalten-Kosmetikum mit Antioxidantien
DE102009027105A1 (de) * 2009-06-23 2010-12-30 Henkel Ag & Co. Kgaa Sonnenschutzzusammensetzungen mit verbessertem antioxidativen Potenzial
DE102009027199A1 (de) * 2009-06-25 2010-12-30 Henkel Ag & Co. Kgaa UV-Schutz-Kosmetikum
DE102010062915A1 (de) * 2010-12-13 2012-06-14 Henkel Ag & Co. Kgaa Synergistische Wirkstoffkombination zum Schutz der Haut vor IR-Strahlung
DE102011079256A1 (de) * 2011-07-15 2013-01-17 Henkel Ag & Co. Kgaa Sonnenschutzzusammensetzungen mit verbessertem antioxidativen Potenzial zum Schutz der Haut vor IR-Strahlung
JP2017088496A (ja) * 2014-03-19 2017-05-25 三菱化学株式会社 皮膚外用剤
EP3370689B1 (de) * 2015-11-02 2023-10-04 Lubrizol Advanced Materials, Inc. Zusammensetzung zum schutz der haut gegen die auswirkungen von verschmutzung und verwendung davon
DE102016225095B4 (de) 2016-12-15 2024-08-29 Henkel Ag & Co. Kgaa "Kosmetische Gesichtspflegeformulierungen zur Stimulierung der körpereigenen Abwehr gegen freie Radikale"
KR101784331B1 (ko) * 2017-02-27 2017-10-12 주식회사 아제라바이오텍 아쿠아포린-3의 발현을 증가시키는 6,7-디메톡시-2,2-디메틸-2h-크로멘 및 이의 용도

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03261705A (ja) * 1990-03-09 1991-11-21 Sansho Seiyaku Co Ltd メラニン生成抑制外用剤
FR2695387B1 (fr) * 1992-09-09 1994-10-21 Adir Nouveaux composés benzopyraniques, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
ES2072223B1 (es) * 1993-11-25 1996-03-16 Lipotec Sa Liposomas encapsulando doxorubicina.
KR100381449B1 (ko) * 1994-10-14 2003-07-18 더 리포좀 컴퍼니, 인코퍼레이티드 에테르지질리포좀과이들의제약학적용도
US5643943A (en) * 1994-12-23 1997-07-01 Alcon Laboratories, Inc. Systemic administration of esters and amides of antioxidants which may be used as antioxidant prodrug therapy for oxidative and inflammatory pathogenesis
EP0869773B1 (de) * 1995-12-15 2004-03-24 National Research Council Of Canada Archaeoliposome, koenzym q10 enthaltende archaeoliposome und koenzym q10 enthaltende liposome als adjuvans und wirkstoffabgabevehikel
WO1999037294A2 (en) * 1998-01-26 1999-07-29 Mitokor Mitochondria protecting agents for treating mitochondria associated diseases

Also Published As

Publication number Publication date
DK1002533T3 (da) 2003-03-17
JP4723705B2 (ja) 2011-07-13
EP1002533B1 (de) 2002-12-04
DE69904282T2 (de) 2003-11-06
ES2154560A1 (es) 2001-04-01
ES2154560B1 (es) 2001-12-01
EP1002533A1 (de) 2000-05-24
DE69904282D1 (de) 2003-01-16
PT1002533E (pt) 2003-04-30
ES2189372T3 (es) 2003-07-01
JP2000095684A (ja) 2000-04-04

Similar Documents

Publication Publication Date Title
ATE228836T1 (de) Verwendung von chromane und/oder chromene derivaten zur vermeidung von freien radikalen induzierten oxidativen reaktionen
DE69612303D1 (de) Aryl oder heteroarylamide von tetrahydronaphthalin, chroman, thiochroman oder 1,2,3,4-tetrahydrochinolin-carbonsäuren mit einer retinoid-ähnlichen biologischen aktivität
DE59910682D1 (de) Verwendung von Flavonen, Flavanonen bzw. Flavonoiden zum Schutze von Ascorbinsäure und/oder Ascorbylverbindungen gegen Oxidation
ES2145915T3 (es) Derivados estereoquimicos de la wortmannina.
IL151108A0 (en) Tocopherols, tocotrienols, other chroman and chain derivatives and uses thereof
DE69528470D1 (de) Thienopyridin und thienopyrimidinderivate und ihre verwendung als entzündungshemmende mittel
BG105513A (en) Substituted benzopyran analogs for the treatment of inflammation
MX9302932A (es) Nuevas 4-aza-5&-androstan-3-onas 7b-substituidas como inhibidores de la5&-reductasa.
FI970069L (fi) Menetelmä (2R-3S)-(4-asetoksi-2alfa-bentsoyylioksi-5beta,20-epoksi-1,7beta,10beta-trihydroksi-9-oksotaks-11-en-13alfa-yyli)-3-tert-butoksikarbonyyliamino-3-fenyyli-2-hydroksipropionaatin trihydraatin valmistamiseksi
ATE226201T1 (de) Substituierte pyridylpyrazole
NO20000426L (no) Fremgangsmõte for inhibering av biogendannelse av sulfid
ATE222259T1 (de) Prodrugs von paclitaxel-derivaten
DK0888327T3 (da) Benzopyranderivater, som har antagonistisk virkning imod leukotriener
DE3681642D1 (de) Benzopyran-verbindungen zur behandlung von inkontinenz.
DE68908392D1 (de) Aminomethyl-chroman- und -thiochroman-verbindungen.
CA2340921A1 (en) Use of taxanes to treat brain cancer
DE69331833D1 (de) Verwendung von vitamin d-glykosiden zur behandlung oder prävention von osteoporose
ATE180669T1 (de) Verwendung von pregnanderivaten zur behandlung von tumoren
MXPA02006617A (es) Dihidrobenzopiranos, dihidrobenzotiopiranos, y tetrahidroquinolinas para el tratamiento de desordenes mediados por cox-2.
ATE174026T1 (de) Chromen-derivate mit einer trien-kette zur verwendung bei der behandlung der osteoporose und der entzündlichen erkrankungen
ATE402694T1 (de) Verwendung von 1-phenyl-3-dimethylamino-propan- verbindungen zur therapie der harninkontinenz
WO2000026399A3 (de) Verfahren zur herstellung von quercetin- und isoquercetin-derivaten
DE60230652D1 (de) Arylsulfanyl und heteroarylsulfanyl-derivate zur behandlung von schmerz
ATE290869T1 (de) Verwendung von vitamin d derivaten zur herstellung eines medikaments zur behandlung von bösartigen tumormetastase
ATE314066T1 (de) Verwendung von buprenorphin zur therapie der harninkontinenz

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1002533

Country of ref document: EP